Point72 Middle East FZE’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-14,028	Closed	-$132K	–	317
2023 Q4	$132K	Buy	14,028 +4,589	+49%	+$43.2K	﹤0.01%	627
2023 Q3	$105K	Buy	+9,439	New	+$105K	﹤0.01%	651
2023 Q2	–	Sell	-4,057	Closed	-$164K	–	1143
2023 Q1	$164K	Buy	+4,057	New	+$164K	0.01%	513